Hyperthermia

What is hyperthermia?

Hyperthermia is a treatment method involving the controlled heating of tumour tissues to temperatures typically between 39°C and 45°C for one hour.

This targeted heat therapy works to damage cancer cells directly, but its primary role is enhancing the effectiveness of radiotherapy and chemotherapy.

At moderate temperatures, hyperthermia sensitises tumour cells to radiation and chemotherapy by altering the tumour's microenvironment, improving oxygenation, and inhibiting DNA repair mechanisms.

Clinical studies demonstrate that hyperthermia can significantly increase treatment response rates without adding toxicity when carefully applied, as it affects tumour cells more than surrounding healthy tissues.

How it works

Hyperthermia works by applying controlled heat to tumour tissues. This process primarily enhances the effectiveness of other cancer treatments like radiotherapy and chemotherapy, increasing the likelihood of tumour cell death. The heat affects cancer cells in several ways:

  • Sensitising cells to radiation and chemotherapy: Heat can make cancer cells more susceptible to damage from radiation and chemotherapy by disrupting cellular repair mechanisms, particularly for DNA. More cells are killed with the same dose of radiotherapy. It also increases the cells' response to treatment by reducing their ability to repair the damage caused by these therapies.

  • Improving blood flow and oxygenation: Hyperthermia improves blood flow within the tumour, which increases oxygen levels. Tumours often have low oxygen levels (hypoxia), making them less responsive to radiation. By enhancing oxygenation, hyperthermia makes radiation more effective.

  • Direct thermal damage: At higher sustained temperatures, hyperthermia can directly damage or kill cancer cells by disrupting their structural proteins and cellular functions. This effect is particularly

Why do you need hyperthermia?

Hyperthermia therapy can be particularly beneficial for several types of cancers and certain treatment-resistant or recurrent tumours.

Conditions that may benefit include:

  • Superficial tumours: Cancers close to the skin's surface, such as melanoma, recurrent breast cancer, and head and neck cancers, respond well to hyperthermia because these tumours are easily accessible for localized heat application.

  • Deep-seated tumours: Hyperthermia can also target deeper tumours when combined with other treatments. Cancers of the cervix, bladder, rectum, and prostate can benefit, especially when hyperthermia is used with radiotherapy to enhance treatment effects.

  • Recurrent tumours: Hyperthermia is often effective in cases where cancer recurs in a previously treated area. Radiation doses are limited in repeat treatments due to the risk of damaging surrounding healthy tissue, but adding hyperthermia can help overcome this challenge by enhancing the effects of radiation at lower doses.

  • Tumours with hypoxic or resistant cells: Cancers with hypoxic (low-oxygen) cells are typically more resistant to radiation. Hyperthermia improves blood flow and oxygenation in the tumour, making these cells more sensitive to radiation.

  • Soft tissue sarcomas: Hyperthermia has shown success in treating certain soft tissue sarcomas, especially when combined with radiation or chemotherapy.

  • Advanced or unresectable tumours: In cases where tumours are inoperable due to size, location, or stage, hyperthermia can help to control tumour growth, reduce symptoms, and potentially improve overall treatment outcomes when used as an adjunct therapy.

Research is ongoing, and the use of hyperthermia in combination with immunotherapy and other advanced treatments is showing promise in expanding its potential applications.

Why should not undergo hyperthermia?

While hyperthermia is a promising adjunct therapy for many cancers, certain individuals may not be suitable candidates. Contraindications and precautions include:

  • Patients with metal implants: Metal implants, like joint replacements or pacemakers, can absorb heat and make it difficult to control the temperature during hyperthermia therapy. This could lead to overheating in the surrounding tissue, potentially causing burns or tissue damage.

  • Patients with cardiovascular or respiratory issues: Those with serious heart or lung conditions may have difficulty tolerating the increased body temperature and blood flow associated with hyperthermia. In these cases, the stress of treatment might outweigh the benefits.

  • Pregnant individuals: Due to potential risks to the fetus from increased body temperatures, hyperthermia is generally avoided during pregnancy.

  • Patients with certain autoimmune diseases: Conditions such as systemic lupus erythematosus (SLE) can make patients more susceptible to tissue damage or immune system reactions, which may be exacerbated by heat.

  • Compromised skin integrity: For those with extensive skin wounds or burns, applying heat directly may worsen the injury or lead to infection. Hyperthermia may be avoided or adjusted based on skin health and wound location.

  • Patients unable to tolerate elevated temperatures: Some people are more sensitive to heat due to individual tolerance or specific conditions, which could increase the risk of side effects.

What are the risks and complications of hyperthermia?

Hyperthermia therapy, while generally well-tolerated, does carry some risks and potential complications. These can vary based on the treatment area, temperature, and the patient’s overall health.

Some risks and complications include:

  • Skin burns: Overheating the skin or tissues near the treatment area can cause burns, especially in superficial hyperthermia where heat is applied closer to the skin.

  • Pain or discomfort: Some patients may feel mild to moderate pain or discomfort in the treated area, particularly if the temperature is difficult to control or maintain evenly. This can include a sensation of warmth or even mild tenderness after treatment.

  • Fatigue and malaise: General tiredness or feeling unwell is a possible side effect due to the body's reaction to the heat, especially in whole body hyperthermia treatments.

  • Local sensitivity and pigmentation changes: Some patients may experience sensitivity in the treated area or temporary skin color changes. These changes are usually temporary but can sometimes last for several weeks post-treatment.

Close monitoring and precise temperature control are key to minimising these risks. Hyperthermia treatments are often adapted to each patient's tolerance, with lower temperatures used if needed to reduce side effects.

Your doctor would be able to discuss detailed specific side effects specific to your condition.

Why choose Gleneagles Hospital?

We deliver expert, compassionate cancer care tailored to each patient’s needs. From early diagnosis to modern treatment options, rehabilitation, and palliative services, we provide seamless, end-to-end support throughout every stage of the cancer journey.

Our radiation oncologists

At Gleneagles Hospital, our radiation oncologists combine deep clinical expertise with modern treatments like hyperthermia to improve outcomes for cancer patients. With a focus on personalised care, they prioritise your comfort and peace of mind throughout your journey.

 Male
 Female
Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.

^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
0 LISTINGS
This page has been reviewed by our medical content reviewers.

Need help?


For enquiries, please call
+65 6575 7575

For appointment bookings, please WhatsApp
+65 8111 9777